Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: A meta-regression of randomized clinical trials

Atherosclerosis - Tập 226 Số 1 - Trang 178-185 - 2013
Fabrizio D’Ascenzo1, Pierfrancesco Agostoni2, Antonio Abbate3,4, Davide Castagno1, Michael J. Lipinski3,4, George W. Vetrovec3,4, Giacomo Frati5, Davide Giacomo Presutti1, Giorgio Quadri1, Claudio Moretti1, Fiorenzo Gaïta1, Giuseppe Biondi‐Zoccai5
1Division of Cardiology, University of Turin, Italy
2Department of Cardiology, University Medical Center Utrecht, the Netherlands
3UNIVERSITY OF VIRGINIA, Charlottesville, VA USA
4Virginia Commonwealth University, Richmond, VA USA
5Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

Huisman, 2011, Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update, Eur J Echocardiogr, 12, 313, 10.1093/ejechocard/jer017

Kern, 2001, Evaluation of the culprit plaque and the physiological significance of coronary atherosclerotic narrowings, Circulation, 103, 3142, 10.1161/01.CIR.103.25.3142

Tardif, 2008, Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial, Atherosclerosis, 197, 480, 10.1016/j.atherosclerosis.2006.11.039

Tardif, 2004, Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions, Circulation, 110, 3372, 10.1161/01.CIR.0000147777.12010.EF

Nissen, 2008, Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial, J Am Med Assoc, 299, 1561, 10.1001/jama.299.13.1561

Hirohata, 2010, Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial, J Am Coll Cardiol, 55, 976, 10.1016/j.jacc.2009.09.062

Fayad, 2012, The time has come for clinical cardiovascular trials with plaque characterization as an endpoint, Eur Heart J, 33, 160, 10.1093/eurheartj/ehr243

Biondi-Zoccai, 2011, Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry, Clin Res Cardiol, 100, 1021, 10.1007/s00392-011-0336-x

Rodriguez-Granillo, 2006, Reproducibility of intravascular ultrasound radiofrequency data analysis: implications for the design of longitudinal studies, Int J Cardiovasc Imaging, 22, 621, 10.1007/s10554-006-9080-0

Yokoyama, 2005, Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study, Am Heart J, 150, 287, 10.1016/j.ahj.2005.03.059

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535

Moher, 1999, Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses, Lancet, 354, 1896, 10.1016/S0140-6736(99)04149-5

2009

Biondi-Zoccai, 2005, Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression, Am Heart J, 149, 504, 10.1016/j.ahj.2004.10.026

Yamada, 2007, Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study, Circ J, 71, 1845, 10.1253/circj.71.1845

Takarada, 2010, The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound, JACC Cardiovasc Interv, 3, 766, 10.1016/j.jcin.2010.05.001

Waseda, 2006, Impact of angiotensin II receptor blockers on the progression and regression of coronary atherosclerosis: an intravascular ultrasound study, Circ J, 70, 1111, 10.1253/circj.70.1111

Wakeyama, 2003, Effects of candesartan and probucol on restenosis after coronary stenting: results of insight of stent intimal hyperplasia inhibition by new angiotensin II receptor antagonist (ISHIN) trial, Circ J, 67, 519, 10.1253/circj.67.519

von Birgelen, 2003, Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound, Circulation, 108, 2757, 10.1161/01.CIR.0000103664.47406.49

Tsuchikane, 1998, Impact of cilostazol on intimal proliferation after directional coronary atherectomy, Am Heart J, 135, 495, 10.1016/S0002-8703(98)70327-8

Toi, 2009, Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin, Circ J, 73, 1466, 10.1253/circj.CJ-08-1051

Tani, 2010, Coronary plaque regression and lifestyle modification in patients treated with pravastatin – assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol, Circ J, 74, 954, 10.1253/circj.CJ-09-0705

Tani, 2009, Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment, Am J Cardiol, 104, 464, 10.1016/j.amjcard.2009.04.009

Tani, 2009, Association of body mass index with coronary plaque regression: 6-month prospective study, J Atheroscler Thromb, 16, 275, 10.5551/jat.E653

Takashima, 2007, Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque, Circ J, 71, 1678, 10.1253/circj.71.1678

Arai, 2010, More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome – sub-analysis of JAPAN-ACS study, J Atheroscler Thromb, 17, 1096, 10.5551/jat.5660

Ballantyne, 2008, Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden, Circulation, 117, 2458, 10.1161/CIRCULATIONAHA.108.773747

Hong, 2010, Usual dose of simvastatin does not inhibit plaque progression and lumen loss at the peri-stent reference segments after bare-metal stent implantation: a serial intravascular ultrasound analysis, Korean J Intern Med, 25, 356, 10.3904/kjim.2010.25.4.356

Iwata, 2011, Association between plasma pigment epithelium-derived factor levels and tissue characteristics of coronary plaque using integrated backscatter intravascular ultrasound, Intern Med, 50, 1889, 10.2169/internalmedicine.50.5460

Jensen, 2004, Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study, Circulation, 110, 265, 10.1161/01.CIR.0000135215.75876.41

Kornowski, 1998, Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients, Am J Cardiol, 81, 1298, 10.1016/S0002-9149(98)00157-X

Kovarnik, 2011, Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration, Circ J, 76, 176, 10.1253/circj.CJ-11-0730

Nakayama, 2010, Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: a randomized prospective study using intravascular ultrasound, Int J Cardiol, 138, 157, 10.1016/j.ijcard.2008.08.031

Hong, 2007, Serial intravascular ultrasound evidence of both plaque stabilization and lesion progression inpatients with ruptured coronary plaques: effects of statin therapy on ruptured coronary plaque, Atherosclerosis, 191, 107, 10.1016/j.atherosclerosis.2006.02.040

Nicholls, 2008, Circulation, 118, 2506, 10.1161/CIRCULATIONAHA.108.790733

Nicholls, 2006, Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano, J Am Coll Cardiol, 47, 992, 10.1016/j.jacc.2005.11.040

Nicholls, 2007, Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis, J Am Med Assoc, 297, 499, 10.1001/jama.297.5.499

Nissen, 2003, Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial, J Am Med Assoc, 290, 2292, 10.1001/jama.290.17.2292

Nissen, 2005, Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease, N Engl J Med, 352, 29, 10.1056/NEJMoa042000

Nissen, 2006, Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial, J Am Med Assoc, 295, 1556, 10.1001/jama.295.13.jpc60002

Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

Ogasawara, 2009, Pioglitazone reduces the necrotic-core component in coronary plaque in association with enhanced plasma adiponectin in patients with type 2 diabetes mellitus, Circ J, 73, 343, 10.1253/circj.CJ-08-0699

Otagiri, 2011, Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study), Circ J, 75, 633, 10.1253/circj.CJ-10-0600

Brener, 2006, Am Heart J, 152, 1059, 10.1016/j.ahj.2006.07.022

Takayama, 2009, Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS), Circ J, 73, 2110, 10.1253/circj.CJ-09-0358

Hong, 2009, Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis, JACC Cardiovasc Interv, 2, 679, 10.1016/j.jcin.2009.03.015

Kawasaki, 2005, Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound, J Am Coll Cardiol, 45, 1946, 10.1016/j.jacc.2004.09.081

Clementi, 2009, Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis, J Cardiovasc Med (Hagerstown), 10, 231, 10.2459/JCM.0b013e3283212eb6

Hibi, 2011, Atherosclerosis, 219, 743, 10.1016/j.atherosclerosis.2011.08.024

Hirayama, 2009, Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy, Circ J, 73, 718, 10.1253/circj.CJ-08-0755

Hirayama, 2011, Plaque-stabilizing effect of atorvastatin is stronger for plaques evaluated as more unstable by angioscopy and intravenous ultrasound, Circ J, 75, 1448, 10.1253/circj.CJ-10-1035

Hiro, 2010, Circ J, 74, 1165, 10.1253/circj.CJ-09-0766

Takagi, 1997, Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin, Am J Cardiol, 79, 1673, 10.1016/S0002-9149(97)00221-X

Tardif, 2007, Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial, J Am Med Assoc, 297, 1675, 10.1001/jama.297.15.jpc70004

Kojima, 2011, Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo University (ALPS-J), Circ J, 75, 1071, 10.1253/circj.CJ-11-0141

Schartl, 2001, of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease, Circulation, 104, 387, 10.1161/hc2901.093188

Lüscher, 2009, A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study, Eur Heart J, 30, 1590, 10.1093/eurheartj/ehp151

Hiro, 2009, J Am Coll Cardiol, 54, 293, 10.1016/j.jacc.2009.04.033

Nicholls, 2011, Effect of two intensive statin regimens on progression of coronary disease, N Engl J Med, 365, 2078, 10.1056/NEJMoa1110874

Nissen, 2006, Effect of ACAT inhibition on the progression of coronary atherosclerosis, N Engl J Med, 354, 1253, 10.1056/NEJMoa054699

Nissen, 2008, obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial, J Am Med Assoc, 299, 1547, 10.1001/jama.299.13.1547

Nissen, 2004, Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial, J Am Med Assoc, 292, 2217, 10.1001/jama.292.18.2217

Nissen, 2007, ILLUSTRATE Investigators. Effect of torcetrapib on the progression of coronary atherosclerosis, N Engl J Med, 356, 1304, 10.1056/NEJMoa070635

Nissen, 2004, Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial, J Am Med Assoc, 291, 1071, 10.1001/jama.291.9.1071

Rodriguez-Granillo, 2007, Effect of perindopril on coronary remodelling: insights from a multicentre, randomized study, Eur Heart J, 28, 2326, 10.1093/eurheartj/ehm255

Okazaki, 2004, Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study, Circulation, 110, 1061, 10.1161/01.CIR.0000140261.58966.A4

Dawber, 1951, Epidemiological approaches to heart disease: the Framingham study, Am J Public Health Nations Health, 41, 279, 10.2105/AJPH.41.3.279

Jousilahti, 1999, Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland, Circulation, 99, 1165, 10.1161/01.CIR.99.9.1165

Wasserman, 2008, Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the Multi-Ethnic Study of Atherosclerosis (MESA), Stroke, 39, 329, 10.1161/STROKEAHA.107.498634

Tonstad, 1996, Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects, Arterioscler Thromb Vasc Biol, 16, 984, 10.1161/01.ATV.16.8.984

Zheng, 2011, The relationship between volumetric plaque components and classical cardiovascular risk factors and the metabolic syndrome a 3-vessel coronary artery virtual histology-intravascular ultrasound analysis, JACC Cardiovasc Interv, 4, 503, 10.1016/j.jcin.2010.12.015

Cliff, 1988, The coronary arteries in cases of cardiac and noncardiac sudden death, Am J Pathol, 132, 319

Detrano, 2008, Coronary calcium as a predictor of coronary events in four racial or ethnic groups, N Engl J Med, 358, 1336, 10.1056/NEJMoa072100

Greenland, 2004, Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals, J Am Med Assoc, 291, 210, 10.1001/jama.291.2.210

Nicholls, 2010, Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome, J Am Coll Cardiol, 55, 2399, 10.1016/j.jacc.2010.02.026

von Birgelen, 2003, Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (= or >12 months) follow-up intravascular ultrasound, Circulation, 108, 2757, 10.1161/01.CIR.0000103664.47406.49

Bulbulia, 2011, Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial, Lancet, 378, 2013, 10.1016/S0140-6736(11)61125-2

Nabel, 2012, A tale of coronary artery disease and myocardial infarction, N Engl J Med, 366, 54, 10.1056/NEJMra1112570

Costanzo, 2010, Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials, J Am Coll Cardiol, 56, 2006, 10.1016/j.jacc.2010.05.059

Biondi-Zoccai, 2007, Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression, Am Heart J, 153, 587, 10.1016/j.ahj.2007.01.007

Morton SC, Adams JL, Suttorp MJ, Shekelle PG. Meta-regression approaches: what, why, when, and how? Technical Reviews, No. 8.